Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVF Cells for Diabetic Peripheral Neuropathy
NCT07553468Completed
- Start
- Dec 2024
- Primary completion
- Feb 2026
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous adipose stromal vascular fraction in diabetic peripheral neuropathy (DPN) and diabetic foot ulcer (DFU). Primary endpoint: Foot Ulcer Healing at 48 weeks. Started Dec 2024; status: completed.
02
Drugs
autologous adipose stromal vascular fraction
03
Conditions
diabetic peripheral neuropathy (DPN)diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT07553468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07553468.